Individual characteristics of the participants. by Surakshya Khanal (19949745)

Subjects:

Physiological regions considering ventricular depth variations. by Inmaculada Villanueva-Baxarias (21454246)

Subjects:

Factors associated with practice regarding osteoporosis among the study participants. by Surakshya Khanal (19949745)

Subjects:

Comparison of the computational model’s healthy baseline simulated traces (black) with those obtained by ultrasound from control cases (grey), after manually tuning the model’s par... by Inmaculada Villanueva-Baxarias (21454246)

Subjects:

Factors associated with knowledge regarding osteoporosis among the study participants. by Surakshya Khanal (19949745)

Subjects:

Confirmed aortic coarctation case at 32 weeks of gestation. by Inmaculada Villanueva-Baxarias (21454246)

Subjects:

Attitude regarding osteoporosis among the study participants. by Surakshya Khanal (19949745)

Subjects:

Confidence intervals for physiological regions. by Inmaculada Villanueva-Baxarias (21454246)

Subjects:

Knowledge regarding osteoporosis among the study participants. by Surakshya Khanal (19949745)

Subjects:

Shares of antibiotic substances on total prescription in UTI treatment (N39.0, N30.0) by sex and age group in 2019 (female: n = 238.670 prescriptions; male: n = 40.641 prescription... by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

Shares of antibiotic substances on total prescription by quarter from 2013 to 2019 for female and male patients with UTI (N39.0, N30.0)(female: n = 1.681.255 prescriptions; male: n... by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

Shares of specialist groups prescribing 1^st, 2^nd, and 3^rd antibiotic prescriptions in UTI treatment of females (N39.0, N30.0) in 2018 and 2019. by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

Number of antibiotic prescriptions in female and male patients with UTI (N30.0 and/or N39.0). by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

Shares of antibiotic substances on total prescription in female patients with UTI (N39.0, N30.0) by physician specialties (GPs: n = 1.299.641 prescriptions; gynecologists n = 141.8... by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

Comparison of 1^st, 2^nd, and 3^rd antibiotic prescription. by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

UTI diagnoses by sex and physician specialty (2013–2019). by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

Additional file 3 of Single-cell profiling reveals a reduced epithelial defense system, decreased immune responses and the immune regulatory roles of different fibroblast subpopula... by Lin Lin (46073)

“…P values were calculated via the two-sided Wilcoxon test. ns, not significant, **, P < 0.01 and ****, P < 0.0001. (G) Feature plot showing LDLR expression levels in C1Q+ macrophages between CAG and control samples.…”

Correlation matrix depicting significant (p ≤ 0.05) Spearman correlations between the relative abundance of root endophytic bacterial major phyla/class and the chemical characteris... by Rabiath F. R. Adigoun (14189090)

Subjects:

Advantages of Novel Anti-cancer Selenosemicarbazones: Preferential Reactivity of Their Fe(III), Cu(II), and Zn(II) Complexes with Key Physiological Reductants/Ligands Versus Isoste... by Mahendiran Dharmasivam (14165426)

“…The role of glutathione in all three latter reactions is significant, given the greater reactivity of the selenosemicarbazone, and glutathione’s key role in selenosemicarbazone and thiosemicarbazone anticancer activity.…”

Advantages of Novel Anti-cancer Selenosemicarbazones: Preferential Reactivity of Their Fe(III), Cu(II), and Zn(II) Complexes with Key Physiological Reductants/Ligands Versus Isoste... by Mahendiran Dharmasivam (14165426)

“…The role of glutathione in all three latter reactions is significant, given the greater reactivity of the selenosemicarbazone, and glutathione’s key role in selenosemicarbazone and thiosemicarbazone anticancer activity.…”